Alex Loftis

Investor

About

Recognized in 2024 as one of 24 rising biotech investors, Alex Loftis has training in chemical biology, peptide therapeutics and protein engineering plus expertise in peptide drug discovery and antigen-specific immune tolerance.

Invests in

BiotechHealthtech

Colleagues at Vida Ventures

Alessandro Giacometti

Vice President, Head of Investor Relations at Vida Ventures

Alex Mejia

Executive Services Manager at Vida Ventures

Alex Shen

Director of Operations at Vida Ventures

Andy Kadlec

Senior Associate at Vida Ventures

Anita Keenan

Executive Assistant at Vida Ventures

Arie Belldegrun

Founder and Senior Managing Director at Vida Ventures

Arjun Goyal

Managing Director at Vida Ventures

Brian Goodman

Managing Director at Vida Ventures